Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)

SHA:600222 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	343.86	180.04	196.67	311.38	380.55	487.32
Trading Asset Securities	-	80.02	153.3	74.96	285.67	207.46
Cash & Short-Term Investments	343.86	260.05	349.97	386.34	666.22	694.78
Cash Growth	-13.55%	-25.69%	-9.41%	-42.01%	-4.11%	20.92%
Accounts Receivable	1,230	1,137	1,056	1,038	744.71	689.25
Other Receivables	32.77	36.38	44.01	51.15	56.44	78.65
Receivables	1,263	1,173	1,100	1,089	801.15	767.89
Inventory	478.7	367.67	455.5	450.49	381.85	348.14
Other Current Assets	113.37	105.35	87.88	105.03	94.49	71.56
Total Current Assets	2,199	1,906	1,993	2,031	1,944	1,882
Property, Plant & Equipment	483.21	501.82	529.65	551.13	539.58	494.09
Long-Term Investments	506.4	526.67	520.38	490.93	825.63	533.76
Goodwill	286.49	286.49	286.49	286.49	286.49	286.49
Other Intangible Assets	50.34	51.17	52.5	48.11	53.1	57.54
Long-Term Deferred Tax Assets	114.04	113.2	94.24	95.38	52.4	47.16
Long-Term Deferred Charges	48.05	52.8	49.81	54.23	35.81	32.98
Other Long-Term Assets	50.83	51.55	50.71	49.08	47.05	54.99
Total Assets	3,738	3,490	3,577	3,607	3,784	3,389
Accounts Payable	343	294.89	470.29	548.89	355.65	211.71
Accrued Expenses	6.53	28.26	24.27	32.22	22.45	20.56
Short-Term Debt	638.59	663.42	381.84	404.87	973.58	750.22
Current Portion of Long-Term Debt	123.01	270.07	89.76	4.22	158.74	406.21
Current Portion of Leases	-	46.29	35.35	26.89	-	-
Current Income Taxes Payable	9.76	1.28	2.53	21.86	3.7	2.98
Current Unearned Revenue	5.94	6.54	11.62	88.26	49.47	61.27
Other Current Liabilities	776.46	483.76	634.5	598.82	86.09	50.94
Total Current Liabilities	1,903	1,795	1,650	1,726	1,650	1,504
Long-Term Debt	134.87	3.02	183.8	192.8	20.37	136.38
Long-Term Leases	28.29	42.04	89.29	37.14	72.06	31.6
Long-Term Unearned Revenue	2.53	2.78	3.26	1.71	-	-
Long-Term Deferred Tax Liabilities	19.84	21.16	25.36	33.26	132.42	56.96
Other Long-Term Liabilities	-	-	1.62	1.62	131.62	130
Total Liabilities	2,089	1,864	1,953	1,993	2,006	1,859
Common Stock	573.89	573.89	573.89	573.89	573.89	573.89
Additional Paid-In Capital	675.17	675.17	675.17	675.17	588.14	588.14
Retained Earnings	360.71	316.01	281.01	237.46	232.15	235.16
Treasury Stock	-109.8	-101.01	-79.72	-37.66	-48.7	-98.47
Comprehensive Income & Other	92.86	110.67	128.15	121.56	315.04	154.7
Total Common Equity	1,593	1,575	1,578	1,570	1,661	1,453
Minority Interest	56.66	51.51	44.89	43.62	117.13	77.16
Shareholders' Equity	1,649	1,626	1,623	1,614	1,778	1,531
Total Liabilities & Equity	3,738	3,490	3,577	3,607	3,784	3,389
Total Debt	924.76	1,025	780.03	665.92	1,225	1,324
Net Cash (Debt)	-580.9	-764.79	-430.07	-279.58	-558.53	-629.62
Net Cash Per Share	-1.05	-1.37	-0.76	-0.50	-1.00	-1.15
Filing Date Shares Outstanding	552.92	554.67	559.36	566.69	563.04	545.98
Total Common Shares Outstanding	552.92	554.67	559.36	566.69	563.04	545.98
Working Capital	295.65	111.55	342.93	305.21	294.03	378.49
Book Value Per Share	2.88	2.84	2.82	2.77	2.95	2.66
Tangible Book Value	1,256	1,237	1,239	1,236	1,321	1,109
Tangible Book Value Per Share	2.27	2.23	2.22	2.18	2.35	2.03
Buildings	-	556.93	543.26	534.9	520.76	516.81
Machinery	-	361.45	341.92	316.19	281.14	247.95
Construction In Progress	-	29.2	28.9	31.1	33.02	24.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.